Renaissance Technologies’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-326,622
| Closed | -$2.73M | – | 4024 |
|
2023
Q3 | $2.73M | Buy |
+326,622
| New | +$2.73M | ﹤0.01% | 1683 |
|
2022
Q3 | – | Sell |
-114,200
| Closed | -$505K | – | 4322 |
|
2022
Q2 | $505K | Sell |
114,200
-754,500
| -87% | -$3.34M | ﹤0.01% | 3162 |
|
2022
Q1 | $7.91M | Buy |
+868,700
| New | +$7.91M | 0.01% | 1281 |
|
2021
Q4 | – | Sell |
-273,800
| Closed | -$7M | – | 4140 |
|
2021
Q3 | $7M | Sell |
273,800
-547,000
| -67% | -$14M | 0.01% | 1252 |
|
2021
Q2 | $28.7M | Buy |
820,800
+37,300
| +5% | +$1.3M | 0.04% | 554 |
|
2021
Q1 | $26.1M | Buy |
+783,500
| New | +$26.1M | 0.03% | 633 |
|
2018
Q1 | – | Sell |
-113,900
| Closed | -$301K | – | 3518 |
|
2017
Q4 | $301K | Buy |
+113,900
| New | +$301K | ﹤0.01% | 3024 |
|
2016
Q4 | – | Sell |
-374,900
| Closed | -$3.36M | – | 3395 |
|
2016
Q3 | $3.36M | Sell |
374,900
-29,164
| -7% | -$261K | 0.01% | 1870 |
|
2016
Q2 | $2.84M | Sell |
404,064
-784,636
| -66% | -$5.52M | 0.01% | 1978 |
|
2016
Q1 | $10.1M | Sell |
1,188,700
-397,700
| -25% | -$3.38M | 0.02% | 1130 |
|
2015
Q4 | $20.8M | Buy |
+1,586,400
| New | +$20.8M | 0.05% | 526 |
|
2015
Q3 | – | Sell |
-309,500
| Closed | -$1.78M | – | 3308 |
|
2015
Q2 | $1.78M | Buy |
309,500
+184,300
| +147% | +$1.06M | ﹤0.01% | 2136 |
|
2015
Q1 | $731K | Sell |
125,200
-12,772
| -9% | -$74.6K | ﹤0.01% | 2460 |
|
2014
Q4 | $1.08M | Buy |
+137,972
| New | +$1.08M | ﹤0.01% | 2094 |
|
2014
Q2 | – | Sell |
-105,766
| Closed | -$566K | – | 2916 |
|
2014
Q1 | $566K | Buy |
+105,766
| New | +$566K | ﹤0.01% | 2310 |
|
2013
Q4 | – | Sell |
-280,100
| Closed | -$1.55M | – | 2981 |
|
2013
Q3 | $1.55M | Buy |
280,100
+4,100
| +1% | +$22.6K | ﹤0.01% | 1799 |
|
2013
Q2 | $698K | Buy |
+276,000
| New | +$698K | ﹤0.01% | 2099 |
|